You are here: Industry Insights > VITT

News List

Possible identification of blood clot trigger for AstraZeneca COVID-19 vaccine PharmaTimes
December 03, 2021
Researchers have identified in those patients experiencing blood clots after vaccination a subsequent condition referred to as vaccine-induced immune thrombotic thrombocytopenia (VITT).
NICE publishes ‘rapid’ guideline on rare blood clots associated with COVID-19 jab pharmatimes
August 02, 2021
The UK’s National Institute for Health and Care Excellence (NICE) has published a new guideline of the rare syndrome vaccine-induced immune thrombocytopenia and thrombosis (VITT) associated with COVID-19 vaccination.
NICE to develop guideline for rare blood clots associated with COVID-19 vaccination pharmatimes
July 15, 2021
The National Institute for Health and Care Excellence (NICE) will develop a guideline on the management and treatment of rare blood clots and low platelet counts associated with COVID-19 vaccination.
New treatment demonstrated for people with vaccine clots firstwordpharma
June 10, 2021
A new lifesaving treatment for people suffering from vaccine-related blood clots has been demonstrated by scientists at McMaster University.